Consultant lobbyist
Kerry Allerton
3Sixty Public Affairs Inc.
- Meetings this Parliament
- 5
- Since Nov 2021
- 5
- Active registrations
- 3
Kerry Allerton's lobbying: the clients they represent and every meeting they've reported since November 2021.
← LobbyingReported meetings
-
- Robina Khan · Pharmacist Consultant, Indigenous Services Canada (ISC)
- Angel Ding · Senior Manager, Policy, Indigenous Services Canada (ISC)
- Michelle Mujoomdar · Senior Manager, Policy, Indigenous Services Canada (ISC)
- Karen Fortin · Executive Director, Indigenous Services Canada (ISC)
and 1 moreShow fewer
- Jacqueline Kosche · Director, Public Health Agency of Canada (PHAC)
Discuss the Vaccine Voucher Demonstration Project, a time-limited, federally funded initiative focused on improving equitable access to shingles vaccination for Canadians aged 50+ Read more
-
- Justine Frame · Policy Advisor, Health Canada (HC)
Discuss the Vaccine Voucher Demonstration Project, a time-limited, federally funded initiative focused on improving equitable access to shingles vaccination for Canadians aged 50+ Read more
-
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Raising awareness of OBI’s federated Intelligence Network for Brain Health Data and expanding its capabilities beyond Ontario. The objective of the federal engagement is to raise awareness of OBI and its impact on brain health, artificial intelligence, and the growth and scale?up of brain health SMEs in Ontario. Over time, this engagement aims to expand OBI’s federated learning model beyond Ontario and position Canada as a global leader in AI, data sovereignty, and brain health. Read more
-
- Samir Khan · Director, Health Canada (HC)
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada Read more
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a priority of the government
Engagement with officials regarding Health Canada’s National Rare Disease Drug Strategy, and other aspects of national pharmacare, including proposals for a Canada Drug Agency and a national formulary
-
- Samir Khan · Director, Health Canada (HC)
Raise awareness of challenges that cancer clinicians face on behalf of their patients in receiving equitable access to cancer care, specifically: - expanding access to diagnostics, including molecular genetics testing - ensuring faster, more equitable access to new cancer therapies - improving efficiencies in patient care, and addressing human resource contraints Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.